Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Astellas Pharma Inc and Ganymed Pharmaceuticals AG a biopharmaceutical company located in Mainz Germany which focuses on the development of antibodies against cancer announced today that Astellas and Ganymeds shareholders have entered into an agreement for Astellas to acquire Ganymed The transaction..
China Resources Pharmaceutical Group Ltd fell in its Hong Kong trading debut after raising about 18 billion in the largest initial public offering globally from a drugmaker since 2013 The stock traded 35 percent lower at HK878 at 944 am in Hong Kong The Beijingbased company priced its IPO at HK910 ..
Aerie Pharmaceuticals reports positive topline efficacy results of ROCKET 4 phase 3 trial of Rhopressatm netarsudil ophthalmic solution 002 percent Aerie Pharmaceuticals Inc Study successfully achieves primary efficacy endpoint Aerie Pharmaceuticals Inc Company separately announces withdrawal of..
AstraZeneca39s high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold following instances of bleeding The drugmaker said the US Food and Drug Administration FDA had placed a partial hold on e..
Auven Therapeutics an international private equity company focused on accelerated development of breakthrough therapeutic drugs today announced the execution of definitive agreements for the sale of 100 percent of Ocular Technologies Sarl a wholly owned Auven subsidiary through which all SecieraTM O..
Privately held drugmaker Kaleo Inc announced on Wednesday plans for a US relaunch of its AuviQ injector for lifethreatening allergic reactions in the first half of next year AuviQ designed to deliver the same epinephrine drug as Mylan NV39s EpiPen was recalled from the market last year amid concern..
Minerva neurosciences announces positive data from sixmonth extension of phase iib trial of min101 monotherapy in schizophrenia Minerva neurosciences min101 was reported to be well tolerated at both doses over entire 36week duration of study by schizophrenic patients Minerva neurosciences positive..
Horizon Pharma plc HZNP a biopharmaceutical company focused on improving patients39 lives by identifying developing acquiring and commercializing differentiated and accessible medicines that address unmet medical needs today announced that it has completed the acquisition of Raptor Pharmaceutical Co..
Nordic Nanovector ASA announces it has entered into a collaboration with Heidelberg Pharma GmbH a subsidiary of biopharmaceutical company WILEX AG FSE WL6 specializing in the development of antibodydrug conjugates ADCs to develop novel ADCs for treating leukaemias Leukaemias are orphan diseases with..
Novartis expects a more difficult pricing environment for drugs in the United States in the years ahead its chief executive told a results conference call on Tuesday We expect pricing to become more difficult in the US over the next three to five years Joe Jimenez said Both major US presidential c..